Search For Additional Tests

Search Form
     
VASOACTIVE INTESTINAL POLYPEPTIDE
Number 973
CPT Code 84586
Alias 
Specimen Container Lavender Top
Specimen Type Plasma EDTA with Trasylol
Turn Around Time 
Days Performed 
Reference Range 0.0-58.8 pg/mL
Alternate Specimen 
Volume 2 mL Plasma
Stability Ambient N/A
Stability Refrigerated N/A
Stability Frozen Preferred
Patient Preparation 

Patient must not have received radioactive substances 24 hours prior to test. Patient should receive at least 300 grams of carbohydrate daily for three days before fasting 12 hours.

Methodology 

Radioimmunoassay (RIA)

Limitations 

Not all patients with the syndrome have increased VIP. Increased VIP can be found in healthy controls and in laxative abusers

Rejection Criteria 

Sample not collected with Trasylol®; sample not submitted in tube with Trasylol label, gross hemolysis; recently administered radioisotopes; specimen not received frozen; serum, sodium citrate, or heparinized plasma specimen; lipemia

Additional Instructions 
Performing Laboratory Reference Laboratory
TagsVIP, PANCREATIC

COVID-19 Testing Guidance

Primex Clinical Laboratories strives to provide clients with quality testing services to better support patient health. With the ongoing pandemic, COVID-19 testing has become high in demand yet testing supplies are limited.

Read More

COVID-19 Testing Guidance

Primex Clinical Laboratories strives to provide clients with quality testing services to better support patient health. With the ongoing pandemic, COVID-19 testing has become high in demand yet testing supplies are limited.

Read More